Clinical and molecular epidemiology of hospital Enterococcus faecalis isolates in eastern France

Clinical Microbiology and Infection

Volumn 5, Issue 3, 1999, Pages 149-157

  Mulin, Blandine ^a   Bailly, Pascale ^a   Thouverez, Michelle ^a   Cailleaux, Vincent ^a   Cornette, Christian ^a   Dupont, Marie Jeanne ^a   Talon, Daniel ^a   Bonnin, Martine ^b   Chantelat, Pascaf ^b   Febvre, Claudine ^b   Mermet, Fabienne ^b   Tronel, Hubert ^b  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b Hôpital Jean Minjoz ^*

Author keywords

Enterococcus faecalis; High level aminoglycoside resistance; Molecular epidemiology; Risk factors

Indexed keywords

BACTERIAL DNA; GENTAMICIN; KANAMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CASE CONTROL STUDY; ENTEROCOCCUS FAECALIS; FEMALE; FRANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS;

EID: 0033063119     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1999.tb00528.x     Document Type: Article

References (38)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including role of the microbiology laboratory. Clin Microbiol Rev 1993; 6: 428-42.
2. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
3. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable VanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1148-53.
4. Bonilla HF, Zervos MA, Lyons MJ, et al. Colonization with vancomycin-resistant Enterococcus faecium: comparison of a long-term-care unit with an acute-care hospital. Infect Control Hosp Epidemiol 1997; 18: 333-9.
5. Pegues DA, Pegues CF, Hibberd PL, Ford DS, Hooper DC. Emergence and dissemination of a highly vancomycin-resistant VanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol 1997; 35: 1565-70.
6. Dunne W, Wang W. Clonal dissemination and colony morpho-type variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan. J Clin Microbiol 1997; 35: 388-92.
7. Chow JW, Kuritza A, Shlaes DM, Green M, Sahm DF, Zervos MJ. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. Antimicrob Agents Chemother 1993; 31: 1609-11.
8. Moreno F, Grota P, Crisp C, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995; 21: 1234-7.
9. Boyle JF, Soumakis SA, Rendo A, et al. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol 1993; 31: 1280-5.
10. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-33.
11. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117: 112-16.
12. Antalek MD, Mylotte JM, Lesse AJ, Sellick JA. Clinical and molecular epidemiology of Enterococcus faecalis bacteremia, with special reference to strains with high-level resistance to gentamicin. Clin Infect Dis 1995; 20: 103-9.
13. Murray BE, Lopardo HA, Rubeglio EA, Frosolono M, Singh KV. Intrahospital spread of a single gentamicin-resistant, β-lactamase-producing strain of Enterococcus faecalis in Argentina. Antimicrob Agents Chemother 1992; 36: 230-2.
14. Thal LA, Chow JW, Patterson JE, et al. Molecular characterization of highly gentamicin-resistant Enterococcus faecalis isolates lacking high-level streptomycin resistance. Antimicrob Agents Chemother 1993; 37: 134-7.
15. Straut M, de Cespédès G, Delbos F, Horaud T. Molecular typing of Enterococcus faecalis strains resistant to high levels of gentamicin and isolated in Romania. J Antimicrob Chemother 1997; 39: 483-91.
16. Hall LMC, Duke B, Urwin G, Guiney M. Epidemiology of Enterococcus faecalis urinary tract infection in a teaching hospital in London, United Kingdom. J Clin Microbiol 1992; 30: 1953-7.
17. Zervos MJ, Mikesell TS, Schaberg DR. Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates of Streptococcus faecalis. Antimicrob Agents Chemother 1986; 30: 78-81.
18. Report of the comité de l'antibiogramme de la Société Française de Microbiologie. Clin Microbiol Intect 1996; 2 (suppl 1).
19. Murray BE, Singh KV, Heath JD, Sharma BR, Weinstock GM. Comparison of genomic DNA of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990; 28: 2059-63.
20. Murray BE, Singh KV, Markowitz SM, et al. Evidence for clonal spread of a single strain of β-lactamase-producing Enterococcus faecalis to six hospitals in five states. J Infect Dis 1991; 163: 780-5.
21. Struelens MJ, Bax R, Deplano A, Quint WGV, Van Belkum A. Concordant clonal delineation of methicillin-resistant Staphylococcus aureus by macrorestriction analysis and polymerase chain reaction genome fingerprinting. J Clin Microbiol 1993; 31: 1964-70.
22. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
23. Kaplan E, Meier P. Non parametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457-81.
24. Cutler SJ, Ederer F. Maximum utilization of the life-table method m analyzing survival. J Chron Dis 1958; 8: 699-713.
25. Peto R, Peto J. Asymptomatically efficient rank invariant test procedures (with discussion). J R Stat Soc 1972; 135: 185-206.
26. Cytel Software. LogXact. Cambridge, Massachusetts: CYTEL Software Corporation, 1993.
27. Chenoweth C, Schaberg DR. The epidemiology of enterococci. Eur J Clin Microbiol Infect Dis 1990; 9: 80-9.
28. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (suppl 3B): 72S-5S.
29. Eliopoulos GM. Increasing problems in the therapy of enterococcal infections. Eur J Clin Microbiol Infect Dis 1993; 12: 409-12.
30. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
31. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev 1994; 7: 462-78.
32. Hall LMC. Recent advances in understanding the epidemiology of enterococci. Rev Med Microbiol 1993; 4: 192-7.
33. Leclerq R. Enterococci acquire new kinds of resistance. Clin Infect Dis 1997; 24(suppl 1): 80S-4S.
34. Vandamme P, Vercauteren E, Lammens C, et al. Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996; 34: 2572-6.
35. Zervos MJ, Dembinski S, Mikesell T, Schaberg DR. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis 1986; 153: 1075-83.
36. Noskin GA, Till M, Patterson BK, Clarke JT, Warren JR. High-level resistance in Enterococcus faecalis bacteriemia. J Infect Dis 1991; 164: 1212-5.
37. Huycke MM, Spiegel CA, Gilmore MS. Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1991; 35: 1626-34.
38. Woodford N, Jones BL, Baccus Z, Ludlam HA, Brown DFJ. Linkage of vancomycin and high-level gentamicin resistance genes on the same plasmid in a clinical isolate of Enterococcus faecalis. J Antimicrob Chemother 1995; 35: 179-84.